As of October 31, 2019, the largest concentration of Candida auris cases — 427 of 911 confirmed cases — is in New York4, according to an article on the Infection Control Today website.
“Approximately 3 years into the New York outbreak, these pan-resistant isolates still appear to be rare, but their emergence is concerning,” investigators have said.
C. auris cases in New York are primarily concentrated among hospital patients and nursing home residents in New York City.
The investigators recommended that patients on antifungal treatment for C. auris should be monitored closely for clinical improvement, and follow-up cultures should be obtained.
Preparing Healthcare Facilities for Wildfire Air Quality Events
UW Health Set to Open Expansion at East Madison Hospital
Central Ohio Primary Care Physicians Falls Victim to Cyberattack
The Role of Biophilic Design in Healthcare Facilities
TriStar Centennial Medical Center Invests $90M in Women, Children's Hospital Expansions